1. 一站式药筛
  2. 虚拟筛选
1M Drug Fragment-Based Diversity Library

Cat. No.: HY-L0113V

MCE 1M Drug Fragment-Based Diversity Library 由 100 万种类药化合物组成。该分子库中的每个化合物都含有至少 1个 较复杂的药物片段,这些药物片段来自 FDA批准的 2,946 个药物分子,以提高化合物的类药性。计算化合物的 BMS (Bemis-Murcko Scaffold) 骨架后,每个 BMS 骨架选择 1~3 个药物片段数较高的化合物,以占据更广泛的“类药化学空间”。

本多样性库具备类药性,化合物骨架多样性等特性,是发现先导化合物的有力工具,可以广泛应用于AI药物筛选、大型虚拟筛选等。

  • Chinese National Compound Library
- +

Compound Screening Libraries

产品详情

Biological activity

•   Each selected compound contains a least one drug fragment. Each drug fragment are derived from 2946 FDA-approved drugs by BRICS and Recap algorithm and the simple fragment were removed.

•   1,000,000 drug-like compounds contain 702,902 unique BM scaffolds (Bemis-Murcko).

•   For each BM scaffold, 1 to 3 compounds with higher number of drug fragments were selected to occupy a broader ‘drug-like chemical space’.

•   Compounds passed all MedChem selection filters, particularly pan assay interference compound (PAINS) motifs, to remove any inappropriate chemical structures and avoid false hits.

定制您专属的化合物库
  •  特定化合物
  •  化合物数量
  •  产品排布图
  •  浓度
  •  形式(固体或溶液)
  •  YES
联系专家定制
  • Chinese National Compound Library

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
1M Drug Fragment-Based Diversity Library
目录号:
HY-L0113V
需求量: